Geon Investment Inc. is a venture capital firm specializing in expansion stage and growth capital. For venture investments, the firm considers investments in following industries: Digital and mobile contents, biotechnology, mobile/online game and movie/music contents. Primarily invests between KRW 500 million ($0.5 million) and KRW 2 billion ($2 million) in equity per transaction in companies. The firm was established in 2009 and is based in Seongnam, South Korea.
Albam : A mobile based HR Solution that is available for both Managers(Admins) and Staffs in App both IOS & Android. The average HR manager spends 45 minutes a day to calculate time attendance & payroll. With Albam, time is reduced by 70% to only 15 minutes. Albam help enterprises in simplifying and automating their time attendance system to payroll solution. Our easy to use and simple Cloud based Human Resource solution helps companies in reducing the high costs that are often associated in the investment of Time Attendance system which includes the purchase of expensive fingerprint machines and training of IT Personnels. With Albam, employees can clock in and clock out directly right away from their smartphone, clock in and clock out has never been this easier with Albam.
swIDch is an information technology company that offers secure authentication through dynamic codes. Through our patented algorithm, we enable our clients to generate dynamic authentication codes in a network-less environment, that can alone be used to authenticate users. The company was founded in 2015 and headquartered in London, England.
Neuraly, a startup biotech company, was formed in 2016 following foundational research by world class neuroscientists led by Ted Dawson, M.D., Ph.D., Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases and Director of the Institute for Cell Engineering at the Johns Hopkins School of Medicine. Following the acquisition of exclusive licenses to patents covering the composition of matter and methods of use, research supporting the development of NLY01 was recently published in Nature Medicine1. These data demonstrated the critical role of the glial compartment of the neural tissue in the pathogenesis of neurodegenerative diseases such as Parkinson's and Alzheimer's diseases.
D&D Pharmatech is a operator of a holding company created to fund the development of therapeutic medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. The company's product pipeline focuses on a range of indications including neurodegenerative, metabolic and fibrotic diseases, providing the opportunity to accelerate the translation of cutting-edge research into lifesaving therapeutic products for patients.
OliPass is always collaborating to develop new ways to give a happy and healthy existence for everyone on the planet. OliPass Corporation is dedicated to changing people's perceptions of life sciences and improving their quality of life.
Mobirix is a mobile game provider. Mobirix provides contents that users can enjoy without age and cultural differences. Mobirix tries to make firm and cooperative relationships with partners to achieve mutual goals. Mobirix will try harder to provide the best gaming experience to millions of gamers all around the world. Player always comes first.
G Plus Games Co., Ltd. was founded in 2011 to create a new era of next gen online entertainment in the global market. By employs over 20 veteran developers who experienced to develop triple A online gaming products for many years, their goal is to create Final Bullet, next generation online shooter which can be published in over the world with groundbreaking brand-new technologies, features, functions and contents. As they are an independent studio, fully ready to work with any global publishers, on any platforms, and prepare any of culturalization and localization for game design, arts, digital materials, contents and development schedules in support their corporate vision.
Pmd Academy engages in the education business in South Korea.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.